血常规指标联合血清肿瘤标志物检测对原发性肝癌的诊断价值观察被引量：4

下载PDF

导出

摘要目的观察血常规指标联合血清肿瘤标志物在原发性肝癌诊断中的价值。方法选取2017年7月—2018年7月我院收治的42例原发性肝癌患者作为观察组,另选择25例慢性乙肝患者作为对照组。比较2组中性粒细胞淋巴细胞比值(NLR)、白细胞(WBC)、甲胎蛋白(AFP)以及癌抗原19-9(CA19-9)值;并比较观察组单用肿瘤标志物与联合血常规检测阳性率。结果观察组NLR、WBC、AFP以及CA19-9值均高于对照组;观察组采用血常规+肿瘤标志物检测阳性率高于单用肿瘤标志物,差异有统计学意义(P<0.05)。结论 NLR、WBC、AFP以及CA19-9值在诊断原发性肝癌中具有一定价值,可为早期临床诊断及患者预后提供客观依据。

作者黄海舰

机构地区婺源县人民医院

出处《基层医学论坛》 2019年第17期2457-2458,共2页 The Medical Forum

关键词血常规血清肿瘤标志物原发性肝癌诊断价值

分类号 R735.7 [医药卫生—肿瘤]

引文网络
相关文献

参考文献5

1陆林敏,张卫平.PD-1/PDL-1及CTLA-4抑制剂治疗原发性肝癌的研究进展[J].浙江医学,2018,40(13):1516-1519. 被引量：7
2肖作汉,孟冈,王立志.血清4项肿瘤标志物联合检测在原发性肝癌诊断中的应用价值[J].实用癌症杂志,2015,30(3):345-347. 被引量：26
3李乔,郭宏华.血中性粒细胞/淋巴细胞比率与相关肝脏疾病预后关系的研究进展[J].临床肝胆病杂志,2017,33(4):780-784. 被引量：12
4王述莲,呼建民,何光伦,王成彬.血清肿瘤标志物联合血常规指标检测在原发性肝癌诊断中的应用研究[J].标记免疫分析与临床,2017,24(1):4-7. 被引量：64
5卢凌鹏,黄艳芳.血清中AFP,GPC3,DCP和VEGF 4种肿瘤标志物对原发性肝癌的早期诊断价值[J].实用癌症杂志,2016,31(9):1399-1401. 被引量：36

二级参考文献35

1Hui Liu, Li-Jie Zhang,Peng Li, Yun Zhai, Yu-Fen Tan, Ning Li, Hui-Guo Ding,Chun-Feng Qu.Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(35):4410-4415. 被引量：57
2黄彩云,韩素桂,张景华,杨颖,胡文俭,周秀艳,赵洪焕,刘启为,刘洪梅,马龙滨,徐康,李颖.甲胎蛋白异质体/甲胎蛋白检测联合CT扫描在原发性肝癌诊断中的价值[J].肿瘤防治研究,2014,41(2):163-165. 被引量：10
3Xiangyi Liu,Xiaohua Wan,Zhongwu Li,Changqing Lin,Yutao Zhan,Xinxin Lu.Golgi protein 73(GP73), a useful serum marker in liver diseases[J]. Clinical Chemistry and Laboratory Medicine . 2011 (8) 被引量：2
4Kentaroh Yamamoto,Hiroshi Imamura,Yutaka Matsuyama,Yukio Kume,Hitoshi Ikeda,Gary L. Norman,Zakera Shums,Taku Aoki,Kiyoshi Hasegawa,Yoshifumi Beck,Yasuhiko Sugawara,Norihiro Kokudo.AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC[J]. Journal of Gastroenterology . 2010 (12) 被引量：6
5Jorge A. Marrero,Patrick R. Romano,Olga Nikolaeva,Laura Steel,Anand Mehta,Claus J. Fimmel,Mary Ann Comunale,Anthony D’Amelio,Anna S. Lok,Timothy M. Block.GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma[J]. Journal of Hepatology . 2005 (6) 被引量：5
6Giulia Malaguarnera,Maria Giordano,Isabella Paladina,Massimiliano Berretta,Alessandro Cappellani,Mariano Malaguarnera.Serum Markers of Hepatocellular Carcinoma. Digestive Diseases . 2010 被引量：1
7Khien V V,Mao H V,Chinh T T,et al.Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. International Journal of Biological Markers . 2001 被引量：1
8Timothy M. Block,Mary Ann Comunale,Melissa Lowman,Laura F. Steel,Patrick R. Romano,Claus Fimmel,Bud C. Tennant,W. Thomas London,Alison A. Evans,Baruch S. Blumberg,Raymond A. Dwek,Tajinder S. Mattu,AnS. Mehta.Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proceedings of the National Academy of Sciences of the United States of America . 2005 被引量：1
9Hippo Y,Watanabe K,Watanabe A,et al.Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Research . 2004 被引量：1
10Li Y L,Ma H B,Guo J X, et al.The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma. ZhonghuaShi Yan He Lin Chuang Bing Du Xue Za Zhi . 2008 被引量：1